EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.452
https://www.valueinhealthjournal.com/article/S1098-3015(24)00567-9/fulltext
Title :
EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00567-9&doi=10.1016/j.jval.2024.03.452
First page :
Section Title :
Open access? :
No
Section Order :
11797